Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study

Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study

Purpose To investigate the eligibility for faricimab in a real-world diabetic macular oedema (DMO) population to the YOSEMITE and RHINE trials, and to compare the eligible DMO populations to the trial populations.Design, settings and participants This retrospective cross-sectional analysis used data...

Full description

Saved in:
Bibliographic Details
Main Authors: Helena Norberg, Inger Westborg, Ayat Al-Najjar
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/2/e089801.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items